Highlights PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Market Closed - Xetra Other stock markets 09:06:28 10/05/2024 pm IST			5-day change	1st Jan Change
22.8 ^EUR	-0.87%		-0.87%	+1.33%

29/04	PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023	CI
18/04	PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023	19/04	CI
PharmaSGP Holding SE Announces Changes to Dividend Policy	19/04	CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023	29/11	CI
Tranche Update on PharmaSGP Holding SE's Equity Buyback Plan announced on January 9, 2023.	28/23/28	CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
PharmaSGP Completes EUR2 Million Share Buyback Program	11/23/11	MT
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
PharmaSGP Holding SE commences an Equity Buyback Plan, under the authorization approved on May 28, 2020.	09/23/09	CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2022	30/22/30	CI
PharmaSGP Holding SE Reports Earnings Results for the Half Year Ended June 30, 2022	28/22/28	CI
PharmaSGP Holding SE Reaffirms Earnings Guidance for the Year 2022	01/22/01	CI
PharmaSGP Holding SE Provides Earnings Guidance for the Fiscal Year 2022	15/22/15	CI
PharmaSGP Holding SE Approves Dividend	15/22/15	CI
PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2022	31/22/31	CI
PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
PharmaSGP Holding SE Provides Revenues Guidance for the Financial Year 2022	25/22/25	CI
PharmaSGP Proposes Dividend for 2021	04/22/04	CI
PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2021	30/21/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights PharmaSGP Holding SE

Equities

PSG

DE000A2P4LJ5

Highlights

Filters